Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

Is the Osmolal Concentration of Ethanol Greater Than Its Molar Concentration?

Background: Recent data suggested that the osmolal gap attributed to ethanol as determined by the difference between measured serum osmolality and calculated serum osmolarity is greater than its molar concentration. The increased osmotic activity of ethanol is thought to be due to its binding to water molecules. This study is conducted to determine the true osmotic contribution of ethanol to serum osmolality. Methods: Baseline serum osmolality and ethanol concentration were measured on each serum sample. Varying amounts of ethanol were added to aliquots of serum in which the baseline serum ethanol concentration was undetectable. Repeat serum osmolality and serum ethanol concentration were measured after addition of ethanol. Results: The range of serum ethanol concentration was 27.3-429.8 mg/dL. The serum osmolal gap attributed solely to ethanol is calculated based on the difference between measured serum osmolality before and measured serum osmolality after addition of ethanol. Our results demonstrated that the contribution of ethanol to serum osmolality can be calculated by dividing the serum ethanol level in mg/dl by 4.6. In addition, the relationship between serum ethanol concentration and osmolal gap due to ethanol was assessed by linear regression analysis. Linear regression analysis relating the osmolal gap due to ethanol and ethanol concentration yielded the following equation: Osmolal Gap (mOsm/kg H2O) = 0.23 (Ethanol [mg/dL]) - 1.43. Conclusion: The osmolal concentration of ethanol can be calculated based on its molar concentration. We found no evidence for ethanol binding to water molecules over the range of ethanol concentration in this study

SAR tomography for the retrieval of forest biomass and height: cross-validation at two tropical forest sites in French Guiana

Developing and improving methods to monitor forest carbon in space and time is a timely challenge, especially for tropical forests. The next European Space Agency Earth Explorer Core Mission BIOMASS will collect synthetic aperture radar (SAR) data globally from employing a multiple baseline orbit during the initial phase of its lifetime. These data will be used for tomographic SAR (TomoSAR) processing, with a vertical resolution of about 20 m, a resolution sufficient to decompose the backscatter signal into two to three layers for most closed-canopy tropical forests. A recent study, conducted in the Paracou site, French Guiana, has already shown that TomoSAR significantly improves the retrieval of forest aboveground biomass (AGB) in a high biomass forest, with an error of only 10% at 1.5-ha resolution. However the degree to which this TomoSAR approach can be transferred from one site to another one has not been assessed. Here, we test this approach at the Nouragues site in central French Guiana (ca 100 km away from Paracou), and develop a method to retrieve the top-of-canopy height from TomoSAR. We found a high correlation between the backscatter signal and AGB in the upper canopy layer (i.e. 20-40 m), while lower layers only showed poor correlations. The relationship between AGB and TomoSAR data at Nouragues was found to be highly similar to the one observed at Paracou. Cross validation using training plots from Nouragues and validation plots from Paracou, and vice versa, gave an error of 16 - 18% of AGB using 1-ha plots. Finally, using a high-resolution LiDAR canopy model as a reference, we showed that TomoSAR has the potential to retrieve the top-of-canopy height with an error to within 2.5 m. Our analyses show that TomoSAR-AGB retrieval method is accurate even in hilly and high-biomass forest areas and suggest that our approach may be generalizable to other study sites, at least those having a canopy taller than 30 m. These results have strong implications for the tomographic phase of the BIOMASS spaceborne mission

Afrisar-Tropisar: Forest biomass retrieval by P-band SAR tomography

International audienc

Hematopoietic SCT activity in Asia: A report from the Asia-Pacific Blood and Marrow Transplantation Group

10.1038/bmt.2010.34Bone Marrow Transplantation45121682-1691BMTR

In vivo inhibition of nuclear ACE2 translocation protects against SARS-CoV-2 replication and lung damage through epigenetic imprinting

International audienceIn vitro, ACE2 translocates to the nucleus to induce SARS-CoV-2 replication. Here, using digital spatial profiling of lung tissues from SARS-CoV-2-infected golden Syrian hamsters, we show that a specific and selective peptide inhibitor of nuclear ACE2 (NACE2i) inhibits viral replication two days after SARS-CoV-2 infection. Moreover, the peptide also prevents inflammation and macrophage infiltration, and increases NK cell infiltration in bronchioles. NACE2i treatment increases the levels of the active histone mark, H3K27ac, restores host translation in infected hamster bronchiolar cells, and leads to an enrichment in methylated ACE2 in hamster bronchioles and lung macrophages, a signature associated with virus protection. In addition, ACE2 methylation is increased in myeloid cells from vaccinated patients and associated with reduced SARS-CoV-2 spike protein expression in monocytes from individuals who have recovered from infection. This protective epigenetic scarring of ACE2 is associated with a reduced latent viral reservoir in monocytes/macrophages and enhanced immune protection against SARS-CoV-2. Nuclear ACE2 may represent a therapeutic target independent of the variant and strain of viruses that use the ACE2 receptor for host cell entry